Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Profit After Tax (2020 - 2025)

Historic Profit After Tax for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to $22.4 million.

  • Pharming's Profit After Tax rose 226982.59% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.8 million, marking a year-over-year increase of 6340.73%. This contributed to the annual value of -$11.8 million for FY2024, which is 1225.82% down from last year.
  • Latest data reveals that Pharming reported Profit After Tax of $22.4 million as of Q3 2025, which was up 226982.59% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Pharming's Profit After Tax registered a high of $22.4 million during Q3 2025, and its lowest value of -$14.9 million during Q1 2025.
  • Over the past 5 years, Pharming's median Profit After Tax value was -$677383.1 (recorded in 2021), while the average stood at -$892950.4.
  • Data for Pharming's Profit After Tax shows a peak YoY increase of 4956561.07% (in 2022) and a maximum YoY decrease of 20138.89% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Pharming's Profit After Tax stood at $14.4 million in 2021, then crashed by 201.39% to -$14.6 million in 2022, then increased by 27.75% to -$10.5 million in 2023, then fell by 4.32% to -$11.0 million in 2024, then soared by 303.89% to $22.4 million in 2025.
  • Its Profit After Tax stands at $22.4 million for Q3 2025, versus -$10.3 million for Q2 2025 and -$14.9 million for Q1 2025.